Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice
- 1 January 1982
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 35 (1) , 105-110
- https://doi.org/10.1128/iai.35.1.105-110.1982
Abstract
A linear correlation coefficient analysis, comparing in vivo anti-infective and reticuloendothelial stimulating activity of several different analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide) suggests that the macrophage is an important target cell for these immunomodulating compounds. The increase in protection against infections of Candida albicans or Pseudomonas aeruginosa in normal or immunosuppressed mice after treatment with 18 different glycopeptides was found to correlate with the degree of clearance of colloidal carbon particles from the blood by the reticuloendothelial system after treatment with the same muramyl dipeptide analogs. The compound which gave the greatest protection in all four assays was N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine followed by N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine. Both analogs were better than the parent muramyl dipeptide. Whether macrophage stimulation alone is responsible for the anti-infective properties of these compounds has not yet been determined.This publication has 29 references indexed in Scilit:
- Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factorPublished by Elsevier ,2004
- Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.The Journal of Experimental Medicine, 1980
- Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.The Journal of Experimental Medicine, 1980
- The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitroInternational Journal of Immunopharmacology, 1979
- Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptideCellular Immunology, 1979
- Inhibition of macrophage migration by synthetic muramyl dipeptideBiochemical and Biophysical Research Communications, 1978
- In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-l-alanyl-d-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder miceCellular Immunology, 1978
- Dissociation between the Adjuvant vs Mitogenic Activity of a Synthetic Muramyl Dipeptide for Murine SplenocytesExperimental Biology and Medicine, 1977
- CELLULAR KINETICS ASSOCIATED WITH THE DEVELOPMENT OF ACQUIRED CELLULAR RESISTANCEThe Journal of Experimental Medicine, 1969
- CELLULAR RESISTANCE TO INFECTIONThe Journal of Experimental Medicine, 1962